Related Experiment Video
Updated: Aug 9, 2026

Cell-free Biochemical Fluorometric Enzymatic Assay for High-throughput Measurement of Lipid Peroxidation in High Density Lipoprotein
Published on: October 12, 2017
Abnormalities in lipoprotein metabolism in hemodialysis patients
M Königer1, T Quaschning, C Wanner
1Department of Medicine, University of Freiburg, Germany. koeniger@mm41.ukl.uni-freiburg.de
Insights
Patients on hemodialysis with hypertriglyceridemia develop abnormal LDL particles. These modified LDLs accumulate, increasing atherosclerosis risk, especially in diabetic patients.
Area of Science:
- Cardiovascular Research
- Lipid Metabolism
- Nephrology
Background:
- Chronic hemodialysis patients face heightened atherosclerosis risk, often linked to dyslipidemia.
- Elevated serum triglycerides are common, while cholesterol and LDL cholesterol remain normal.
Purpose of the Study:
- To investigate how hypertriglyceridemia in hemodialysis patients, with and without diabetes, affects LDL metabolism.
- To analyze the characteristics and cellular uptake of LDL particles in these patient groups.
Main Methods:
- LDL was isolated from healthy controls, hypertriglyceridemic diabetics, and non-diabetic hemodialysis patients.
- LDL subfractions were analyzed for lipid/protein content, glycation, and oxidation.
- LDL uptake was studied using HepG2 cells (LDL receptors) and macrophages (scavenger receptors).
Main Results:
- Hemodialysis patients showed elevated triglycerides with normal cholesterol; LDL particles were enriched with triglycerides.
- A highly atherogenic small dense LDL subfraction accumulated, particularly in diabetic patients.
- Modified LDL from hemodialysis patients had increased lipid peroxidation and impaired LDL receptor uptake, with enhanced scavenger receptor uptake.
Conclusions:
- Impaired LDL receptor uptake of modified, triglyceride-rich, small dense LDL promotes in vivo accumulation and atherosclerosis.
- Further clinical studies are needed to assess the benefits of lipid-lowering interventions for these atherogenic particles.
Background:
Patients on chronic hemodialysis treatment are at elevated atherogenic risk, and dyslipidemia appears to be one of the major risk factors. However, most of these patients exhibit elevated serum triglycerides, whereas serum cholesterol and low-density lipoprotein (LDL) cholesterol levels are in the normal range. This study was therefore designed to examine the influence of hypertriglyceridemia under the condition of hemodialysis and diabetes mellitus on LDL metabolism.
Methods:
LDL was isolated from healthy controls, hypertriglyceridemic diabetic patients, and nondiabetic hemodialysis patients (N = 30, 10 in each group), which were separated into six subfractions by density gradient ultracentrifugation and were characterized concerning lipid/protein composition, degree of glycation, and oxidation. Uptake of 125I-labeled LDL was examined via LDL receptors of HepG2 cells and scavenger receptors of mouse peritoneal macrophages.
Results:
In hemodialysis patients, serum triglycerides were significantly elevated, whereas cholesterol levels were within the normal range. Triglyceride enrichment occurred in the very low-density lipoprotein (VLDL) class and LDL class, and an accumulation of a highly atherogenic small dense LDL subfraction could be detected predominantly in patients with non-insulin-dependent diabetes mellitus. LDL of hemodialysis patients also contained elevated levels of lipid peroxidation products, which were even higher in diabetic patients. Alterations in composition, size, and configuration of LDL from diabetic and nondiabetic patients on hemodialysis impaired LDL receptor-mediated degradation and enhanced the uptake of these modified LDL particles via nonsaturable scavenger receptors.
Conclusion:
Diminished LDL receptor-mediated uptake of modified, triglyceride-rich, small dense LDL most likely leads to accumulation of these lipoproteins in vivo, favoring the development of atherosclerotic lesions. Future clinical studies must demonstrate whether patients will benefit from reducing these atherogenic particles by lipid-lowering intervention.
More Related Videos
Related Concept Videos
Overview of Lipid Metabolism
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
Cholesterol: Significance and Regulation
Considering cholesterol and...
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow
Blood Studies for Cardiovascular System III: Serum Lipid Profile
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
Nephrotic Syndrome I : Introduction
Hemodialysis I: Introduction

